Hikma Pharmaceuticals PLC Sponsored ADR (H5PA)

Overview

Hikma Pharmaceuticals PLC is a global pharmaceutical company founded in 1978 with its headquarters located in London, United Kingdom. The company specializes in the development, manufacturing, marketing, and selling of a wide array of pharmaceutical products. It operates through three primary segments: Injectables, Generics, and Branded. These segments cumulatively cater to a broad spectrum of healthcare needs, encompassing both hospital and retail markets in the United Kingdom, Europe, North America, the Middle East, North Africa, and other international territories.

Products and Services

• Injectables

  This segment focuses on the provision of generic injectable products primarily for hospital use. These injectables cover various therapeutic areas, making Hikma a crucial player in the healthcare system, especially in acute care settings where injectables are often required for immediate patient treatment.

• Generics

  Hikma's Generics segment is dedicated to offering oral and other non-injectable generic products targeted toward the retail market. This includes a wide range of cost-effective treatments for patients, ensuring accessibility to essential medications without compromising on quality.

• Branded

  The Branded segment deals with branded generics and in-licensed products for both retail and hospital markets. These products provide reliable, high-quality alternatives to branded pharmaceuticals, catering to a variety of therapeutic areas and facilitating a broad reach across different healthcare settings.

In addition to these primary segments, Hikma Pharmaceuticals PLC offers a diverse portfolio across several therapeutic areas such as respiratory, oncology, and pain management. The company's comprehensive product lineup is available in multiple dosage forms including solid, semi-solid, liquid, and injectable, enabling it to meet a wide range of patient needs and preferences.